Close Menu

NEW YORK – Throughout the COVID-19 pandemic, a number of researchers including prominent epidemiologists and economists have promoted population-wide rapid antigen testing as a means of controlling transmission of the virus.

A recently launched pilot project in the UK has returned data that sheds light on the effectiveness of such an approach and indicates that it may be more less impactful in practice than in theory.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.